Share

    


Home / Search Results

Search Results

Search Publications

Search Again?

Filter By Content Type

Filter By Topic

You searched for:

New Molecular Entities • None Changes in Labeled Indications • Polivy® (polatuzumb vedotin) --Genentech’s antibody-drug conjugate (ADC), which came to market with an accelerated approval for use (after at least two prior therapies) for patients with relapsed/refractory diffuse large B-cell lymphoma (DLBCL), has now gained FDA’s approval for treating newly diagnosed patients. The …
23-StJoseph-Health-Physician-Education-Dinner-Flyer
Molecular-Testing-Lack-of-Standardized-Reporting-Formats-for-Molecular-Test-Results
State Legislation Fertility Preservation Audit Request Passed May 17, 2022 Last week marked a major milestone with Hawaii's passing of Senate Concurrent Resolution (SCR) 241 in both legislative chambers. The Resolution calls on the Auditor to assess the social and financial effects of mandatory coverage for fertility preservation treatments for those diagnosed with cancer and whose cancer treatment …
Want to promote the ACCC 48th Annual Meeting & Cancer Business Summit in your upcoming newsletter? We’ve created a few sample messages for your convenience. If you want to write your own post, please be sure to include the meeting URL (https://bit.ly/2022AMCCBS). Register Today for the ACCC 48th Annual Meeting & Cancer Business Summit (AMCCBS) AMCCBS will offer countless opportunities to …
« 1 2 3 4 5 6 7 8 » University of Arizona Cancer Center, Banner University Medical Center Tucson Tucson, Arizona Shifting Chemo Administration from Inpatient to Outpatient Setting Improves Care and Reduces Costs At the University of Arizona Cancer Center, Banner University Medical Center Tucson, a multidisciplinary team of physicians, pharmacy staff, finance …
Through education and advocacy, ACCC seeks to improve cancer outcomes for patients diagnosed with adrenal, bladder, kidney (also known as renal), penile, prostate, and testicular cancers.
JF13-Building-an-Oncology-Fellowship-Program
Developing a Research Programƒand How to Make it Work Full Terms & Conditions of access and use can be found at https://www.tandfonline.com/action/journalInformation?journalCode=uacc20 Oncology Issues ISSN: 1046-3356 (Print) 2573-1777 (Online) Journal homepage: https://www.tandfonline.com/loi/uacc20 Developing a Research Program…and How to Make it Work Jo A. Scott To cite this …
JA11-Profile
SO05-Issues
MJ14-Issues
New Patient Guidelines Initiative Announced Full Terms & Conditions of access and use can be found at https://www.tandfonline.com/action/journalInformation?journalCode=uacc20 Oncology Issues ISSN: 1046-3356 (Print) 2573-1777 (Online) Journal homepage: https://www.tandfonline.com/loi/uacc20 New Patient Guidelines Initiative Announced To cite this article: (1994) New Patient Guidelines …
MJ03-First-Person
New ACCC Report Provides in-Depth Information on Hospital Cancer DRGs Full Terms & Conditions of access and use can be found at https://www.tandfonline.com/action/journalInformation?journalCode=uacc20 Oncology Issues ISSN: 1046-3356 (Print) 2573-1777 (Online) Journal homepage: https://www.tandfonline.com/loi/uacc20 New ACCC Report Provides in-Depth Information on Hospital Cancer DRGs …
State Society Policy Pilot Project Policy Engagement Committee Roles & Responsibilities For this pilot project a Policy Engagement Committee will be formed. As a member of the Policy Engagements Committee for the State Society Policy Project, you—along with other from the State Society and patient advocacy organizations —will identify state issues of importance to the patient and provider …
MA08-First-Person
SO06-Tools
ND12-President